Click to copy
Click to copy

NovoCure: 2Q Earnings Snapshot

July 25, 2019

SAINT HELIER, Jersey (AP) _ NovoCure Ltd. (NVCR) on Thursday reported a loss of $1.3 million in its second quarter.

On a per-share basis, the Saint Helier, Jersey-based company said it had a loss of 1 cent.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.

The oncology drug developer posted revenue of $86.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $81.5 million.

NovoCure shares have more than doubled since the beginning of the year. The stock has increased 96% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR

All contents © copyright 2019 The Associated Press. All rights reserved.